Latest Upsher-Smith Laboratories Inc. Stories
MAPLE GROVE, Minn., Sept. 11, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced the availability of a new formulation of B-Nexa(® )Rx Prenatal Vitamin with B Vitamins and Ginger to help calm morning sickness, also known as Nausea and Vomiting of Pregnancy (NVP). The new formulation contains increased amounts of two key ingredients - folic acid and vitamin B6.(1) (Photo: http://photos.prnewswire.com/prnh/20120123/NY39344 ) "It is well recognized that a...
MAPLE GROVE, Minn., Sept. 11, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today introduced its newest addition to the Nexa® prenatal vitamin family -- Nexa(®) Plus Capsules. The once-daily, prescription prenatal vitamin is formulated with 350 mg of plant-based life'sDHA(TM), 1.25 mg folic acid, biotin - an important B-vitamin, essential vitamins and minerals, and a gentle stool softener.(1) (Photo:...
MAPLE GROVE, Minn., Sept. 6, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., the maker of AmLactin® Alpha-Hydroxy Skin Care, announced today the revamping of their website, www.littleredbumps.com, as part of the brand's "Ultra Skin Performance" Campaign. Littleredbumps.com features the expertise of leading New York Cosmetic Dermatologist, Dr. Doris Day, along with five-time Olympian and mom, Dara Torres, to give dry skin sufferers invaluable tips on striving for beautiful skin...
MAPLE GROVE, Minn., Aug. 30, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that it teamed up with The Epilepsy Foundation of Minnesota as one of two title sponsors for the 2012 Stroll for Epilepsy. The Stroll took place on Thursday, August 9, 2012 in five cities across the state of Minnesota and eastern North Dakota to benefit the 60,000 people in the community living with epilepsy. "Upsher-Smith and The Epilepsy Foundation of...
MAPLE GROVE, Minn., June 25, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced the nationwide launch of Provella(TM), a unique probiotic dietary supplement specifically designed for women to promote digestive, feminine, and immune health.* Provella(TM) helps restore and maintain balance of good bacteria to support digestive and vaginal health.* Taken once-daily by mouth, Provella(TM) tablets contain a proprietary blend of six bacteria strains that include:...
MAPLE GROVE, Minn., June 15, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. announced today that it is the recipient of Distribution Industry Awards for Notable Achievements in Healthcare (DIANA) given by the Healthcare Distribution Management Association (HDMA). The Company was presented with two DIANAs, one in the 'Branded Pharmaceutical Product Manufacturer' category. Within this category, Upsher-Smith was the winner for the third year in a row of the 'Best Overall Branded...
MAPLE GROVE, Minn., May 22, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. announced today that Senior National Account Manager, Dave Zitnak received the prestigious McKesson Branded Pharmaceutical Representative of the Year Award at the annual McKesson National Sales Conference in Las Vegas, NV on May 8, 2012. The award was presented by Greg Yonko, Senior Vice President of Purchasing at McKesson. (Photo: http://photos.prnewswire.com/prnh/20120522/NY11654) San Francisco,...
MAPLE GROVE, Minn., May 7, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced the launch of Provella(TM), a probiotic dietary supplement specifically designed for women to promote digestive, feminine and immune health.* Provella(TM) helps restore and maintain balance of good bacteria to support digestive and vaginal health.* Taken once-daily by mouth, Provella(TM) tablets (www.provella.com) contain a proprietary blend of six bacteria strains that include:...
MAPLE GROVE, Minn., April 26, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (http://www.upsher-smith.com) today announced that three posters characterizing the pharmacokinetic (PK) profile of USL255, its once-daily, extended-release (ER) topiramate formulation, were presented at the 64th Annual American Academy of Neurology (AAN) Meeting. One of the posters showed equivalent exposure between USL255 and equal doses of immediate-release (IR) topiramate at steady state, a...
MAPLE GROVE, Minn., April 26, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced the launch of http://www.seizureclusterstudy.com, an informational website for individuals diagnosed with partial or generalized epilepsy who experience seizure clusters and are interested in participating in an ongoing Phase III clinical trial. The study, ARTEMIS1 (Acute Rescue Therapy in Epilepsy with Midazolam Intranasal Spray) is designed to evaluate the efficacy and safety of...
